Latin American Working Group on Gram Positive Resistance, Department of Internal Medicine, Pulmonary Diseases Division, Hospital de Clínicas, Universidad de Buenos Aires, Argentina.
Braz J Infect Dis. 2010 Dec;14 Suppl 2:S119-27. doi: 10.1590/s1413-86702010000800007.
The global spread of methicillin-resistant Staphylococcus aureus (MRSA) means it is now a pathogen of worldwide public health concern. Within Latin America, MRSA is highly prevalent, with the proportion of S. aureus isolates that are methicillin-resistant on the rise, yet resources for managing the infection are limited. While several guidelines exist for the treatment of MRSA infections, many are written for the North American or European setting and need adaptation for use in Latin America. In this article, we aim to emphasize the importance of appropriate treatment of MRSA in the healthcare and community settings of Latin America. We present a summary of the available guidelines and antibiotics, and discuss particular considerations for clinicians treating MRSA in Latin America.
耐甲氧西林金黄色葡萄球菌（MRSA）的全球传播意味着它现在是全球公共卫生关注的病原体。在拉丁美洲，MRSA 极为普遍，耐甲氧西林金黄色葡萄球菌的分离株比例不断上升，但管理感染的资源有限。虽然有一些针对 MRSA 感染治疗的指南，但许多都是为北美或欧洲的情况编写的，需要适应拉丁美洲的情况。在本文中，我们旨在强调在拉丁美洲的医疗保健和社区环境中适当治疗 MRSA 的重要性。我们总结了现有的指南和抗生素，并讨论了拉丁美洲治疗 MRSA 的临床医生的特殊考虑因素。
